78.44
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $78.44, with a volume of 6.49M.
It is up +0.69% in the last 24 hours and up +4.61% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health adds primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$77.90
Open:
$77.54
24h Volume:
6.49M
Relative Volume:
0.87
Market Cap:
$99.49B
Revenue:
$386.46B
Net Income/Loss:
$4.49B
P/E Ratio:
21.89
EPS:
3.5841
Net Cash Flow:
$4.78B
1W Performance:
+2.08%
1M Performance:
+4.61%
6M Performance:
+12.85%
1Y Performance:
+17.72%
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CVS
Cvs Health Corp
|
78.44 | 98.80B | 386.46B | 4.49B | 4.78B | 3.5841 |
![]()
UNH
Unitedhealth Group Inc
|
358.66 | 321.06B | 422.82B | 22.09B | 25.27B | 23.09 |
![]()
ELV
Elevance Health Inc
|
351.42 | 79.54B | 189.25B | 5.35B | 5.34B | 23.49 |
![]()
CI
Cigna Group
|
295.41 | 80.27B | 261.22B | 5.40B | 3.94B | 18.31 |
![]()
HUM
Humana Inc
|
271.00 | 33.70B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-18-25 | Upgrade | UBS | Neutral → Buy |
Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
May-30-24 | Initiated | Robert W. Baird | Neutral |
May-07-24 | Downgrade | TD Cowen | Buy → Hold |
May-02-24 | Downgrade | UBS | Buy → Neutral |
May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Dec-22-23 | Initiated | HSBC Securities | Buy |
Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
May-26-23 | Initiated | Piper Sandler | Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Dec-14-21 | Initiated | Goldman | Buy |
Dec-01-21 | Initiated | Seaport Research Partners | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
Sep-17-20 | Initiated | Piper Sandler | Overweight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
Apr-18-19 | Initiated | Guggenheim | Buy |
Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
Apr-10-19 | Reiterated | BofA/Merrill | Buy |
Mar-13-19 | Initiated | Bernstein | Outperform |
Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Jan-17-19 | Initiated | UBS | Buy |
Dec-18-18 | Initiated | Barclays | Overweight |
Nov-29-18 | Resumed | Goldman | Neutral |
Nov-28-18 | Initiated | Evercore ISI | Outperform |
Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
Feb-27-18 | Resumed | BofA/Merrill | Buy |
Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health (NYSE:CVS) Hits New 52-Week HighShould You Buy? - MarketBeat
Cvs Health Corp stock hits 52-week high at 79.21 USD - Investing.com
Is now a turning point for CVS Health CorporationCEO Change & Short-Term High Return Ideas - newser.com
CVS Launches Workforce Innovation and Talent Center and Community Resource Center in Fort Worth - Yahoo Finance
Concord Asset Management LLC VA Buys Shares of 34,078 CVS Health Corporation $CVS - MarketBeat
Yousif Capital Management LLC Has $15.60 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pzena Investment Management LLC Sells 935,521 Shares of CVS Health Corporation $CVS - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 21,544 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Tops US Medicare Quality Ratings For 2026 - Finimize
Using Bollinger Bands to evaluate CVS Health Corporation2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Rep. Val T. Hoyle Sells CVS Health Corporation (NYSE:CVS) Shares - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Means Investment CO. Inc. - MarketBeat
GFS Advisors LLC Has $248,000 Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Aberdeen Group plc - MarketBeat
US Bancorp DE Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Thompson Investment Management Inc. - MarketBeat
Mengis Capital Management Inc. Decreases Position in CVS Health Corporation $CVS - MarketBeat
Commerzbank Aktiengesellschaft FI Purchases 10,795 Shares of CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Reduces Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Venturi Wealth Management LLC Takes $259,000 Position in CVS Health Corporation $CVS - MarketBeat
Belpointe Asset Management LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026 - The Motley Fool
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Why CVS Health Corporation (CVS) stock appeals to dividend investorsWeekly Volume Report & Daily Price Action Insights - newser.com
Why CVS Health Corporation is moving todayTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
CVS Health (NYSE:CVS) Given New $88.00 Price Target at Mizuho - MarketBeat
CVS Health Leads In Top-Rated Medicare Plans, Edging Out Rivals - Finimize
CVS Health stock rating maintained at Overweight by Cantor Fitzgerald - Investing.com
Technical analysis overview for CVS Health Corporation stockMarket Volume Report & Smart Money Movement Alerts - newser.com
How CVS Health Corporation (CVS) stock compares with tech leadersMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Sector ETF performance correlation with CVS Health CorporationJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
CVS Health stock rating reiterated at Outperform by Mizuho on stable Star Ratings - Investing.com
Golden Reserve Retirement LLC Invests $468,000 in CVS Health Corporation $CVS - MarketBeat
Callan Family Office LLC Buys 89,053 Shares of CVS Health Corporation $CVS - MarketBeat
Leo Wealth LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
Using Ichimoku Cloud for CVS Health Corporation technicals2025 Market Overview & Consistent Income Trade Ideas - newser.com
Optas LLC Takes Position in CVS Health Corporation $CVS - MarketBeat
US health agency releases 2026 quality ratings for Medicare plans - Reuters
US health agency releases 2026 quality ratings for Medicare plans By Reuters - Investing.com
CVS says over 81% of members are in high-rated Medicare Advantage plans for 2026 - Yahoo
Aetna achieves over 81% of Medicare Advantage members in 4-Star plans and over 63% in 4.5-Star plans for 2026 - PR Newswire
CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes Wall Street After Medicare Star Ratings Update - Stocktwits
CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions - The Globe and Mail
CVS Stock Rating Maintained with Raised Price Target by Mizuho | - GuruFocus
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Will CVS Health Corporation stock deliver better than expected guidanceTrade Ideas & Safe Capital Preservation Plans - newser.com
Morey & Quinn Wealth Partners LLC Sells 6,250 Shares of CVS Health Corporation $CVS - MarketBeat
Full technical analysis of CVS Health Corporation stockJuly 2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
Narwhal Capital Management Decreases Stake in CVS Health Corporation $CVS - MarketBeat
Kingswood Wealth Advisors LLC Reduces Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (CVS) Valuation: Is There More Upside After Recent Share Price Gains? - Yahoo Finance
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):